Apogem Capital’s Constellium CSTM Stock Holding History

Apogem Capital’s Portfolio CSTM Stock Details CSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-78,452	Closed	-$796K	–	24
2022 Q3	$796K	Buy	+78,452	New	+$1.04M	0.79%	36
2022 Q2	–	Sell	-52,988	Closed	-$954K	–	164
2022 Q1	$954K	Buy	+52,988	New	+$966K	0.65%	45

Other funds holding CSTM

Bpifrance Maisons Alfort, Cedex, France $1.36B AUM 21.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

NTCM

Nut Tree Capital Management New York $419M AUM 65.06% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Apogem Capital's CSTM Position: Q4 2022 in Review

Apogem Capital sold out of Constellium (CSTM) in Q4 2022, closing a stake of 78,452 shares — an estimated $796K sold.

Apogem Capital first reported a position in CSTM in Q1 2022 and held it in 2 quarters. The position peaked at $954K in Q1 2022. 184 funds tracked by Wall St. Rank hold CSTM as of Q4 2022.

Apogem Capital reported no remaining Constellium position as of Q4 2022 after selling out during the quarter.
Apogem Capital sold 78,452 Constellium shares in Q4 2022, an estimated $796K.
Apogem Capital first reported a position in Constellium in Q1 2022 and held it in 2 quarters.
Apogem Capital's Constellium position peaked at $954K in Q1 2022.
184 funds tracked by Wall St. Rank held Constellium as of Q4 2022.

Based on Apogem Capital's 13F filing for Q4 2022, filed 13 Feb 2023.